At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage repair (DDR)-deficient localized prostate cancer offered new insights -- but ...

The outrage over prescription drug pricing in the U.S. is justified. Americans routinely pay two to three times more for ...

It would impose work requirements for low-income adults to receive Medicaid health insurance and increase them for food ...

By "making T cells happier," the widely used selective serotonin reuptake inhibitor (SSRI) class of antidepressants enhanced ...

While rates of bile duct injury were similar with robotic-assisted cholecystectomy and laparoscopic cholecystectomy among ...

And Arcutis Biotherapeutics announced approval of roflumilast (Zoryve) topical foam 0.3% for plaque psoriasis of the scalp ...

A new FDA policy will make COVID boosters available for high-risk groups, but harder to get for many Americans.

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...

4D-ACS trial investigators found that after placement of a drug-coated stent (DCS), the incidence of net adverse clinical ...

Patients with extensive-stage SCLC often respond to induction therapy, but the disease tends to progress rapidly after cytotoxic therapy ends, said Jared Weiss, MD, of the University of North Carolina ...